Remember that by proving one isomer is better without the other, a
whole new patent becomes available. Oh, and synthetic chemistry has
only recently been able to separate the two commercially.
Now what would you do if you were a drug co?
--
SC
On 23/08/07, Declan Fox <[log in to unmask]> wrote:
> I don't really know. That wee French study just caught my eye because it
> was something so different from anything else I had read on isomers.
> If it means anything at all then we have to see the difference in
> clinical results and I think the experts say the clinical trials do not
> show enough of a difference to justify the expense of escitalopram over
> citalopram. Lundbeck say different, of course. My own impression is that
> escitalopram is a cleaner drug and better for anxiety but that would be
> almost meaningless, were it not for the fact that we all know there is a
> big gap between our everday patients in the surgery and those who get on
> to RCTs. And of course I am a dark agent of big pharma anyway since I
> have earned maybe 2K in the last few years speaking at events organised
> by Lundbeck.
>
|